Sign in

CIK 0001649094

  • Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464233385
Phone
+1 650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 8,910 shares (to pay taxes)
  2. 4 Open-market sale Chief Executive Officer sold 10,000 shares at an average $27.44 ($274,416)
  3. 4 Open-market sale President and CFO sold 36,000 shares at $28.00 ($1,008,000)
  4. 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.93 ($77,785)
  5. 4 Open-market sale President and CFO sold 3,100 shares at an average $25.26 ($78,320)
  6. 4 Open-market sale Chief Operating Officer sold 2,800 shares at $25.15 ($70,407)
  7. 4 Open-market sale Chief Executive Officer sold 11,000 shares at an average $25.58 ($281,402)
  8. 4 Open-market sale VP, Research sold 15,000 shares at an average $25.57 ($383,508)
  9. 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
  10. 4 Open-market sale Chief Executive Officer sold 10,000 shares at an average $23.27 ($232,664)
  11. 4 Open-market sale SVP Process Dev, Manufacturing sold 3,000 shares at $25.00 ($75,000)
  12. 4 Open-market sale President and CFO sold 3,100 shares at an average $24.53 ($76,047)
  13. 4 Open-market sale Chief Executive Officer sold 11,000 shares at an average $24.47 ($269,187)
  14. 4 Open-market sale President and CFO sold 3,100 shares at $24.00 ($74,400)
  15. 4 Open-market sale Chief Operating Officer sold 2,800 shares at $22.00 ($61,600)
  16. 4 Open-market sale Chief Executive Officer sold 10,747 shares at an average $21.00 ($225,696)
  17. 4 Open-market sale Chief Executive Officer sold 10,253 shares at an average $21.03 ($215,639)
  18. 4 Grant or award SVP, Gen Counsel & Corp Sec acquired 7,500 shares (grant or award)
  19. 4 Grant or award Director acquired 3,125 shares (grant or award)
  20. 4 Grant or award Director acquired 3,125 shares (grant or award)

Page 14 of 22 · 421 filings